SEC Form 4 · accession 0000899243-16-019989
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James B Weissman
Officer — Chief Business Officer
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 6:11 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2016 | P | 300 | $3.2399 | A | 15,100 | D | |
| Common StockF1 | May 12, 2016 | P | 530 | $3.2897 | A | 15,630 | D | |
| Common StockF1 | May 12, 2016 | P | 4,170 | $3.2899 | A | 19,800 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).